LOW-VOLUME · HOSP-MID

capsaicin Side Effects

capsaicin (also sold as Zostrix, Qutenza) is a LOW-VOLUME FAERS extract #429 of 524 by FAERS report count. Still opens on HOSP-MID: 19.9% mention hospitalization (602 reports).

Data updated 2026-05-15

3,030
FAERS reports

Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.

capsaicin: 19.9% mention hospitalization (602 reports). Death stamp DEATH-MARKED; volume band LOW-VOLUME #429 of 524 by FAERS report count.

Thinner FAERS extract for capsaicin (Zostrix) (3,030 reports #429 of 524 by FAERS report count). 19.9% mention hospitalization (602 reports). Sparse books still carry named reaction rows when present; not medical advice.

Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.

APPLICATION SITE PAIN leads 475 of 3,030 reports

APPLICATION SITE PAIN
475
PAIN
404
BURNING SENSATION
291
PAIN IN EXTREMITY
178
FATIGUE
162
APPLICATION SITE ERYTHEMA
137
INSOMNIA
101
WEIGHT INCREASED
100
DYSPNOEA
99
NAUSEA
91
ERYTHEMA
89
PARAESTHESIA
88
HYPERTENSION
85
HYPOAESTHESIA
82
DIZZINESS
78
POOR QUALITY SLEEP
76
APPLICATION SITE BURN
74
HERPES ZOSTER
74

Who reports · age peak 45-64 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 1,580 (55%)
Male 1,273 (45%)
Unknown 7

Age peak 45-64 (838 reports)

0-17 32 (2%)
18-44 291 (15%)
45-64 838 (43%)
65-74 433 (22%)
75+ 373 (19%)

FAERS filings rising toward 2025

2004 2025

Reactions in Death Reports

Death appears on 147 reports (4.9% - MARKED). Reactions below co-occur in those rows only.

Reaction Reports
DEATH 57
PNEUMONIA 15
NEOPLASM MALIGNANT 13
ACUTE KIDNEY INJURY 10
MALIGNANT NEOPLASM PROGRESSION 9
ACUTE RESPIRATORY DISTRESS SYNDROME 8
ASTHENIA 8
DRUG INTERACTION 8
DYSPNOEA 7
PAIN 7
SPINAL CORD INJURY 7
TORSADE DE POINTES 7
RENAL FAILURE 6
CARDIAC ARREST 5
GENERAL PHYSICAL HEALTH DETERIORATION 5
MULTIPLE ORGAN DYSFUNCTION SYNDROME 5
MYOCARDIAL INFARCTION 5
BACK PAIN 4
CHRONIC KIDNEY DISEASE 4
GASTROENTERITIS 4

Reactions in Hospitalization Reports

Hospitalization mid-share (602, 19.9%). Co-reported reactions:

Reaction Reports
FATIGUE 101
POOR QUALITY SLEEP 71
IMPAIRED WORK ABILITY 65
INSOMNIA 64
HYPERTENSION 63
IMPAIRED QUALITY OF LIFE 62
WEIGHT INCREASED 62
CELLULITIS 61
HYPERLIPIDAEMIA 59
HERPES ZOSTER 58
CONTUSION 56
SKIN DISORDER 56
BONE DENSITY DECREASED 55
CATARACT 55
BODY TINEA 54
GLUCOSE TOLERANCE IMPAIRED 54
INFECTION SUSCEPTIBILITY INCREASED 54
ORAL HERPES 54
PURPURA 54
How to read capsaicin FAERS figures (SIGNAL · DEATH-MARKED · HOSP-MID)

FAERS holds 3,030 voluntary reports linked to capsaicin (Zostrix, Qutenza), 2004-2025. Death is listed on 147 (4.9%). Hospitalization appears on 602 (19.9%). Top co-reported indication: Diabetic Neuropathy.

Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.

Read with capsaicin

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.